Кластеры и кластерные инициативы в биофармацевтической промышленности России: идентификация, структура, география
The biopharmaceutical industry has always been a highly concentrated sector of the economy. This industry became a matter of great interest in Russia when import-substituting programmes grew in relevance. The implementation of the Pharma-2020 strategy, along with the stable indicators of the economic growth of the industry, facilitated the creation of cluster initiatives — both innovative and innovative local ones — in certain regions of the Russian Federation. A necessary condition for the creation of cluster initiatives is the existence of a high industrial concentration in a rather limited area. The article proposes a methodology that can be used to check whether cluster initiatives match geographic clusters; it also demonstrates how this methodology can be applied to the cluster initiatives created in Russia between 2008 and 2018 in order to verify how they match the geographical clusters established on the basis of spatial indices of industrial concentration. We have established that out of the twenty-four biopharmaceutical clusters considered, eight clusters were created in areas where the relevant industry is not geographically concentrated. We have found regions in which the geographic concentration of the biopharmaceutical industry is rather high, although regional governments did not launch cluster initiatives of the related industries. We have analyzed the structure of the biopharmaceutical cluster initiatives and revealed that: the number of participants is insufficient; the share of industrial plants is low; the industry is not sufficiently specialized; small and average plants are involved only at an average level.